US Drug Recall Register

FDA Drug Recalls

14,801 recalls, newest first

Class I · High risk Terminated

SnoreStop NasoSpray

Reason Microbial contamination of non-sterile product: FDA laboratory analysis found product to contain microbial contamination identified as Providencia rettgeri.

Green Pharmaceuticals, Inc. NDC 61152-199-99 D-1165-2022
Class II · Moderate risk Terminated

Clonidine Transdermal System

Reason Defective Delivery System: Out of specification for release liner removal force results at the 3-month CRT stability timepoint.

Mayne Pharma Inc NDC 51862-455-01 D-1152-2022
Class I · High risk Terminated

Allergy Bee Gone for Kids Nasal Swab Remedy 0.33 FL OZ

Reason Microbial contamination of non-sterile product: FDA laboratory analysis found product to contain elevated levels of yeast and mold as well as the presence of Bacillus cereus.

Buzzagogo, LLC D-1160-2022
Class II · Moderate risk Terminated

CORRECTDOSE Children's COUGH & CHEST CONGESTION DM

Reason CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.

Plastikon Healthcare LLC NDC 62320-321-05 D-1494-2022
Class II · Moderate risk Terminated

CORRECTDOSE Children's PAIN RELIEF & Fever Reducer

Reason CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.

Plastikon Healthcare LLC NDC 62320-311-05 D-1493-2022
Class II · Moderate risk Terminated

CORRECTDOSE Children's ALLERGY RELIEF

Reason CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.

Plastikon Healthcare LLC NDC 62320-302-05 D-1492-2022
Class II · Moderate risk Terminated

GUAIFENESIN AND DEXTROMETHORPHAN 200-20 mg/10 mL

Reason CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.

Plastikon Healthcare LLC NDC 0904-6980-72 D-1491-2022
Class II · Moderate risk Terminated

GUAIFENESIN AND DEXTROMETHORPHAN 100 mg-10 mg/5 mL

Reason CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.

Plastikon Healthcare LLC NDC 0904-6844-70 D-1490-2022
Class II · Moderate risk Terminated

Diphenhydramine HCl Oral Solution

Reason CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.

Plastikon Healthcare LLC NDC 0904-6741-72 D-1489-2022
Class II · Moderate risk Terminated

Diphenhydramine HCl Oral Solution 12.5 mg / 5 mL

Reason CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.

Plastikon Healthcare LLC NDC 0904-6740-70 D-1488-2022
Class II · Moderate risk Terminated

Calcium Carbonate Oral Suspension

Reason CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.

Plastikon Healthcare LLC NDC 0904-7098-94 D-1487-2022
Class II · Moderate risk Terminated

Acetaminophen Oral Solution 650 mg / 20.3 mL

Reason CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.

Plastikon Healthcare LLC NDC 0904-6820-76 D-1486-2022
Class II · Moderate risk Terminated

Acetaminophen Oral Solution

Reason CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.

Plastikon Healthcare LLC NDC 0904-6739-71 D-1485-2022
Class II · Moderate risk Terminated

Acetaminophen Oral Solution 160 mg / 5 mL

Reason CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.

Plastikon Healthcare LLC NDC 0904-6738-70 D-1484-2022
Class II · Moderate risk Terminated

Magnesium Hydroxide 2400 mg

Reason CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.

Plastikon Healthcare LLC NDC 0904-6839-73 D-1483-2022
Class II · Moderate risk Terminated

Magnesium Hydroxide 1200 mg

Reason CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.

Plastikon Healthcare LLC NDC 0904-6838-73 D-1482-2022
Class II · Moderate risk Terminated

Milk of Magnesia USP

Reason CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.

Plastikon Healthcare LLC NDC 0904-6840-72 D-1481-2022
Class II · Moderate risk Terminated

Milk of Magnesia USP

Reason CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.

Plastikon Healthcare LLC NDC 0904-6846-73 D-1480-2022
Class I · High risk Terminated

Magnesium Hydroxide 2400 mg

Reason Microbial Contamination of Non-Sterile Products.

Plastikon Healthcare LLC NDC 0904-6839-73 D-1479-2022
Class I · High risk Terminated

Magnesium Hydroxide 1200 mg

Reason Microbial Contamination of Non-Sterile Products.

Plastikon Healthcare LLC NDC 0904-6838-73 D-1478-2022
Class I · High risk Terminated

Milk of Magnesia USP

Reason Microbial Contamination of Non-Sterile Products.

Plastikon Healthcare LLC NDC 0904-6840-72 D-1477-2022
Class I · High risk Terminated

Milk of Magnesia USP

Reason Microbial Contamination of Non-Sterile Products

Plastikon Healthcare LLC NDC 0904-6846-73 D-1476-2022
Class II · Moderate risk Terminated

Losartan Potassium Tablets

Reason CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits

PD-Rx Pharmaceuticals, Inc. NDC 72789-165-90 D-1163-2022
Class II · Moderate risk Terminated

Losartan Potassium Tablets

Reason CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits

PD-Rx Pharmaceuticals, Inc. NDC 72789-164-90 D-1162-2022
Class II · Moderate risk Terminated

Losartan Potassium Tablets

Reason CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits

PD-Rx Pharmaceuticals, Inc. NDC 72789-163-90 D-1161-2022